Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
The American Journal of Psychiatry
|
March 18, 1999
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment
G E Tsai, W E Falk, J Gunther, et al.
Archives of General Psychiatry
|
February 9, 2000
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group
C H van Dyck, P Newhouse, W E Falk, et al.
Comprehensive Psychiatry
|
January 1, 1989
CDP-choline for the treatment of tardive dyskinesia: a small negative series
A J Gelenberg, J Wojcik, W E Falk, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy study
W E Falk, J F Rosenbaum, D V Sheehan, et al.
The American Journal of Psychiatry
|
April 1, 1988
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital
A J Gelenberg, B Bellinghausen, J D Wojcik, et al.
The Journal of Clinical Psychiatry
|
May 1, 1989
Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
A J Gelenberg, B Bellinghausen, J D Wojcik, et al.
The American Journal of Psychiatry
|
August 1, 1991
A review of 32 cases of tardive dystonia
J D Wojcik, W E Falk, J S Fink, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1988
An open trial of maprotiline for the treatment of cocaine abuse: a pilot study
A W Brotman, S M Witkie, A J Gelenberg, et al.
The Journal of Clinical Psychiatry
|
April 1, 1990
A crossover study of lecithin treatment of tardive dyskinesia
A J Gelenberg, D J Dorer, J D Wojcik, et al.
Comprehensive Psychiatry
|
July 1, 1990
Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo
A J Gelenberg, J D Wojcik, W E Falk, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
The American Journal of Psychiatry
|
March 18, 1999
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment
G E Tsai, W E Falk, J Gunther, et al.
Archives of General Psychiatry
|
February 9, 2000
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group
C H van Dyck, P Newhouse, W E Falk, et al.
Comprehensive Psychiatry
|
January 1, 1989
CDP-choline for the treatment of tardive dyskinesia: a small negative series
A J Gelenberg, J Wojcik, W E Falk, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Suriclone for generalized anxiety disorder: an escalating multiple-dose, safety, tolerance, and efficacy study
W E Falk, J F Rosenbaum, D V Sheehan, et al.
The American Journal of Psychiatry
|
April 1, 1988
A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital
A J Gelenberg, B Bellinghausen, J D Wojcik, et al.
The Journal of Clinical Psychiatry
|
May 1, 1989
Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
A J Gelenberg, B Bellinghausen, J D Wojcik, et al.
The American Journal of Psychiatry
|
August 1, 1991
A review of 32 cases of tardive dystonia
J D Wojcik, W E Falk, J S Fink, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1988
An open trial of maprotiline for the treatment of cocaine abuse: a pilot study
A W Brotman, S M Witkie, A J Gelenberg, et al.
The Journal of Clinical Psychiatry
|
April 1, 1990
A crossover study of lecithin treatment of tardive dyskinesia
A J Gelenberg, D J Dorer, J D Wojcik, et al.
Comprehensive Psychiatry
|
July 1, 1990
Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo
A J Gelenberg, J D Wojcik, W E Falk, et al.
Page
of 4